Dec-12 -

Genito-Urinary Group

EORTC 22911 – Phase III study of post-operative external radiotherapy in pathological stage T3N0 prostatic carcinoma.

Joint study of the EORTC Radiotherapy Cooperative Group and the EORTC Genito-Urinary Tract Cancer Cooperative Group

EORTC’s study with a seven-year follow-up in patients with prostate cancer at high risk of progression, confirmed that immediate external irradiation following complete surgical removal of the prostate improves biochemical progression free survival and local control after five years. Exploratory analyses suggested that postoperative irradiation might improve clinical progression free survival in patients younger than 70 years and in those with positive surgical margins, but could have a detrimental effect in patients 70 and older.


Go to Top